On Wednesday 25 November, the European Commission published its Pharmaceutical Strategy, a first step towards addressing strategic vulnerabilities that are risking Europe’s ability to secure supply...
As a global recession looms, many businesses find themselves facing an existential crisis. The coronavirus pandemic has signalled an end to a period of untrammelled economic...
Rare disease patients in Europe got a boost in late December after a European Medicines Agency (EMA) experts’ panel recommended seven medicines for approval, including two...
Opinion by European Alliance for Peronalised Medicine (EAPM) Executive Director Denis Horgan The concept of personalised medicine has been firmly grasped by many stakeholders, including the...
